Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures

AIM: The use of recombinant human platelet-derived growth factor–BB (rhPDGF) has received Food and Drug Administration approval for the treatment of periodontal and orthopedic bone defects and dermal wound healing. Many studies have investigated its regenerative potential in a variety of other oral...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JDR Clin Trans Res
Asıl Yazarlar: Tavelli, L., Ravidà, A., Barootchi, S., Chambrone, L., Giannobile, W.V.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2020
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961612/
https://ncbi.nlm.nih.gov/pubmed/32392438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2380084420921353
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller